Body iron stores and early neurologic deterioration in acute cerebral infarction

Neurology

Volumn 54, Issue 8, 2000, Pages 1568-1574

  Davalos A ^a   Castillo, J ^b   Marrugat, J ^c   Fernandez Real, J M ^a   Armengou, A ^a   Cacabelos, P ^b   Rama, R ^c  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c NONE

Author keywords

Amino acids; Cerebral infarction; Free radicals; Stroke

Indexed keywords

FERRITIN; GLUTAMIC ACID; IRON;

ADULT; AGED; AMINO ACID ANALYSIS; ARTICLE; BRAIN INFARCTION; CANADA; DETERIORATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; NEUROLOGICAL COMPLICATION; PREDICTION; PRIORITY JOURNAL;

EID: 0343134573     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.8.1568     Document Type: Article

References (40)

1. Dávalos A, Castillo J. Progressing Stroke. In: Fisher M, Bogousslavsky J, eds. Current review of cerebrovascular disease. 3rd ed. Philadelphia: Current Medicine, 1999:149-160.
2. Fisher M, Garcia JH. Evolving stroke and the ischemic penumbra. Neurology 1996;47:884-888.
3. Patt A, Horesh IR, Berger EM, Harken AH, Repine JE. Iron depletion or chelation reduces ischemia/reperfusion-induced edema in gerbil brains. J Pediatr Surg 1990;25:224-228.
4. Davis S, Helfaer MA, Traystman RJ, Hum PD. Parallel antioxidant and antiexcitotoxic therapy improves outcome after incomplete global cerebral ischemia in dogs. Stroke 1997;28: 198-205.
5. Hall ED. Novel inhibitors of iron-dependent lipid peroxidation for neurodegenerative disorders. Ann Neurol 1992;32:S137-S142.
6. Dávalos A, Fernandez-Real JM, Ricart W, et al. Iron-related brain damage in acute ischemic stroke. Stroke 1994;25:1543-1546.
7. Castillo J, Dávalos A, Noya M. Progression of ischaemic stroke and excitotoxic amino acids. Lancet 1997;349:79-83.
8. Dávalos A, Castillo J, Pumar JM, Noya M. Body temperature and fibrinogen are related to early neurological deterioration in acute ischemic stroke. Cerebrovasc Dis 1997;7:64-69.
9. Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993;24:3-41.
10. Côté R, Hachinski VC, Shurvell BL, Norris JW, Wolfson C. The Canadian Neurological Scale: a preliminary study in acute stroke. Stroke 1986;17:731-737.
11. Dávalos A, Crendra E, Teruel J, Martinez M, Genís D. Deteriorating ischemic stroke: risk factors and prognosis. Neurology 1990;40:1865-1869.
12. Côté R, Battista RN, Wolfson C, Boucher J, Adam J, Hachinski V. The Canadian Neurological Scale: validation and reliability assessment. Neurology 1989;39:638-643.
13. Castillo J, Dávalos A, Marrugat J, Noya M. Timing for fever-related brain damage in acute ischemic stroke. Stroke 1998; 29:2455-2460.
14. International Committee for Standardization in Hematology, Expert Panel on Iron. Proposed international standard of human ferritin for the serum ferritin assay. Br J Haematol 1985; 61:61-63.
15. Robert C, Vermont J, Bosson JL. Formulas for threshold computations. Comput Biomed Res 1991;24:514-529.
16. Toni D, Fiorelli M, Gentile M, et al. Progressing neurological deficit secondary to acute ischemic stroke. Arch Neurol 1995; 52:670-675.
17. Dávalos A, Toni D, Iweins F, Lesaffre E, Bastianello S, Castillo J. Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European Cooperative Acute Stroke Study (ECASS) I. Stroke 1999;30: 2631-2636.
18. Armengou A, Dávalos A, Fernandez-Real JM, Castillo J. Serum ferritin concentrations are not modified in the acute phase of ischemic stroke. Stroke 1998;29:258-260. Letter.
19. Cook JD, Finch CA, Smith NJ. Evaluation of the iron status of a population. Blood 1976;3:449-455.
20. Walters GO, Miller FM, Worwood M. Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol 1973; 26:770-772.
21. Zappone E, Bellotti V, Cazzola M, et al. Cerebrospinal fluid ferritin in human disease. Haematologica 1986;71:103-107.
22. Beckman JS. Interactions of oxidants, nitric oxide, and antioxidant defenses in cerebral ischemia and injury. In: Ginsberg MD, Bogousslavsky J, eds. Cerebrovascular disease: pathophysiology, diagnosis, and management. Malden, MA: Blackwell Science, 1998:455-470.
23. Reif DW. Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 1992;12:417-427.
24. Chan PH. Role of oxidants in ischemic brain damage. Stroke 1996;27:1124-1129.
25. Schmidley JW. Free radicals in central nervous system ischemia. Stroke 1990;25:7-12.
26. Nelson CW, Wei EP, Povlishock JT, Kontos HA, Moskowitz MA. Oxygen radicals in cerebral ischemia. Am J Physiol 1992; 263:H1356-H1352.
27. Dávalos A, Castillo J, Serena J, Noya M. Duration of glutamate release after acute ischemic stroke. Stroke 1997;28:708-710.
28. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993;262:689-695.
29. Pellegrini-Giampietro DE, Cherici G, Alesiani M, Carla V, Moroni F. Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J Neurosci 1990;10:1035-1041.
30. Monyer H, Hartley DM, Choi DW. 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures. Neuron 1990;5:121-126.
31. Oh SM, Betz AL. Interaction between free radicals and excitatory amino acids in the formation of ischemic brain edema in rats. Stroke 1991;22:915-921.
32. Morimoto T, Globus MY-T, Busto R, Martinez E, Ginsberg MD. Simultaneous measurement of salicylate hydroxylation and glutamate release in the penumbral cortex following transient middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1996;16:92-99.
33. Oubidar M, Boquillon M, Marie C, Schreiber L, Bralet J. Ischemia-induced brain iron delocalization: effect of iron chelators. Free Radic Biol Med 1994;16:861-867.
34. Lipscomb DC, Gorman LG, Traystman RJ, Hurn PD. Low molecular weight iron in cerebral ischemic acidosis in vivo. Stroke 1998;29:487-493.
35. Kil HY, Zhang J, Piantadosi CA. Brain temperature alters hydroxyl radical production during cerebral ischemia/reperfusion in rats. J Cereb Blood Flow Metab 1996;16:100-106.
36. Fernandez-Real JM, Ricart W, Arroyo E, et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 1998;21:62-68.
37. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F, for the Bruneck Study Group. Body iron stores and the risk of carotid atherosclerosis. Circulation 1997;96:3300-3307.
38. Salonen JK, Nyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-811.
39. Toni D, Fiorelli M, Zanette EM, et al. Early spontaneous improvement and deterioration of ischemic stroke patients: a serial study with transcranial Doppler ultrasonography. Stroke 1998;29:1144-1148.
40. Grau AJ, Buggle F, Becher H, et al. Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies. Neurology 1998;50:196-203.